José is a science news writer with a PhD in Neuroscience from Universidade of Porto, in Portugal. He has also studied Biochemistry at Universidade do Porto and was a postdoctoral associate at Weill Cornell Medicine, in New York, and at The University of Western Ontario in London, Ontario, Canada. His work has ranged from the association of central cardiovascular and pain control to the neurobiological basis of hypertension, and the molecular pathways driving Alzheimer’s disease.
The U.S. Food and Drug Administration granted fast track status to Polyphor’s immuno-oncology candidate balixafortide (POL6326) in combination with Halaven (eribulin mesylate) to treat a subset of patients with ... Read more
The European Medicines Agency has agreed to review an application by AstraZeneca and MSD requesting the approval of Lynparza (olaparib) for the treatment of patients with a difficult-to-treat type of metastatic breast cancer ... Read more
A new blood test could predict how a patient will respond to metastatic breast cancer medication Ibrance (palbociclib) months earlier than current approaches, a U.K. study suggests. Research shows ... Read more
The first patient in the Phase 2 clinical study of MCLA-128 in metastatic breast cancer patients has been dosed, The Netherlands-based immuno-oncology company Merus recently announced. The international study ... Read more
Practicing Tibetan yoga frequently may improve sleep quality in breast cancer patients receiving chemotherapy, research from The University of Texas MD Anderson Cancer Center shows. The study, “Randomized trial ... Read more